| Blue Sky Therapy Services, Llc | |
|
3058 N State Rd Ste E, Davison, MI 48423-3508 | |
| (810) 652-6315 | |
| (810) 652-6213 |
| Full Name | Blue Sky Therapy Services, Llc |
|---|---|
| Type | Facility |
| Speciality | Clinic/center - Rehabilitation |
| Location | 3058 N State Rd Ste E, Davison, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134666373 | NPI | - | NPPES |
| Provider Name | Darin E Nowak |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1629008206 PECOS PAC ID: 2769430412 Enrollment ID: I20050111000102 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
A new ad campaign warns Mississippi legislators that SB 2445 would increase health care costs by granting the State Board of Pharmacy authority to regulate pharmacy benefit managers.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that eventually destroys most motor neurons, causing muscle weakness and atrophy throughout the body. There is no cure and the current treatment has only a moderate effect on the march of the disease, which typically kills within three to five years. This week in PNAS, a team of Brandeis scientists reports an innovative approach to treating the most common form of familial ALS, commonly known as Lou Gehrig's disease.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
› Verified 3 days ago
| Provider Name | Diane E Freeman |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1003000605 PECOS PAC ID: 9537225040 Enrollment ID: I20110805000716 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
A new ad campaign warns Mississippi legislators that SB 2445 would increase health care costs by granting the State Board of Pharmacy authority to regulate pharmacy benefit managers.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that eventually destroys most motor neurons, causing muscle weakness and atrophy throughout the body. There is no cure and the current treatment has only a moderate effect on the march of the disease, which typically kills within three to five years. This week in PNAS, a team of Brandeis scientists reports an innovative approach to treating the most common form of familial ALS, commonly known as Lou Gehrig's disease.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Blue Sky Therapy Services, Llc 3058 N State Rd Ste E, Davison, MI 48423-3508 Ph: (810) 652-6315 | Blue Sky Therapy Services, Llc 3058 N State Rd Ste E, Davison, MI 48423-3508 Ph: (810) 652-6315 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
A new ad campaign warns Mississippi legislators that SB 2445 would increase health care costs by granting the State Board of Pharmacy authority to regulate pharmacy benefit managers.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that eventually destroys most motor neurons, causing muscle weakness and atrophy throughout the body. There is no cure and the current treatment has only a moderate effect on the march of the disease, which typically kills within three to five years. This week in PNAS, a team of Brandeis scientists reports an innovative approach to treating the most common form of familial ALS, commonly known as Lou Gehrig's disease.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
› Verified 3 days ago